Profile
Kari Myren is currently Chief Medical Officer at Oncoinvent ASA since 2021.
Former positions include Non-Executive Director at SoftOx Solutions AS, VP-Global Medical Affairs & Clinical Development at Photocure ASA from 2019 to 2021, and Chief Medical Officer at Oncoinvent ASA (Old).
Education includes an undergraduate degree from the University of Oslo.
Kari Myren active positions
| Companies | Position | Start |
|---|---|---|
| ONCOINVENT ASA | Chief Tech/Sci/R&D Officer | 2020-12-31 |
Former positions of Kari Myren
| Companies | Position | End |
|---|---|---|
| SOFTOX SOLUTIONS | Director/Board Member | 2023-03-23 |
| PHOTOCURE ASA | Chief Tech/Sci/R&D Officer | 2021-09-30 |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Chief Tech/Sci/R&D Officer | - |
Training of Kari Myren
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Photocure ASA
Photocure ASA Medical SpecialtiesHealth Technology Develops and sells pharmaceuticals and medical devices | Health Technology |
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BerGenBio ASA
BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Health Technology |
SoftOx Solutions AS
SoftOx Solutions AS Miscellaneous Commercial ServicesCommercial Services Develops and manufactures non-toxic & antiseptic medicines | Commercial Services |
- Stock Market
- Insiders
- Kari Myren
















